RESONANCE SPECIALTIES
|
RESONANCE SPECIALTIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.57 | 4.33 | 10.71 | 9.12 | 4.77 |
| CEPS(Rs) | 3.83 | 5.61 | 12.22 | 9.97 | 5.57 |
| DPS(Rs) | - | 1.00 | 1.00 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 46.63 | 43.36 | 40.00 | 30.35 | 21.57 |
| Tax Rate(%) | 25.11 | 27.00 | 24.11 | 27.74 | 20.42 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 7.63 | 10.36 | 19.70 | 18.31 | 12.17 |
| EBIT Margin(%) | 6.81 | 10.57 | 19.23 | 19.08 | 11.41 |
| Pre Tax Margin(%) | 6.20 | 10.41 | 19.15 | 18.70 | 10.86 |
| PAT Margin (%) | 4.65 | 7.60 | 14.54 | 13.52 | 8.64 |
| Cash Profit Margin (%) | 6.93 | 9.84 | 16.59 | 14.78 | 10.08 |
| Performance Ratios | |||||
| ROA(%) | 4.25 | 8.16 | 22.19 | 21.98 | 13.89 |
| ROE(%) | 5.71 | 10.39 | 30.44 | 35.11 | 24.08 |
| ROCE(%) | 7.90 | 14.14 | 39.75 | 48.33 | 31.51 |
| Asset Turnover(x) | 0.92 | 1.07 | 1.53 | 1.63 | 1.61 |
| Sales/Fixed Asset(x) | 1.19 | 1.37 | 1.90 | 1.77 | 1.52 |
| Working Capital/Sales(x) | 1.68 | 1.73 | 2.22 | 3.04 | 4.21 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.84 | 0.73 | 0.53 | 0.56 | 0.66 |
| Receivable days | 73.29 | 56.93 | 37.82 | 36.46 | 39.24 |
| Inventory Days | 131.23 | 96.41 | 60.60 | 70.23 | 63.74 |
| Payable days | 100.07 | 84.83 | 72.52 | 107.26 | 116.55 |
| Valuation Parameters | |||||
| PER(x) | 35.08 | 17.90 | 16.47 | 13.76 | 5.29 |
| PCE(x) | 23.53 | 13.82 | 14.43 | 12.58 | 4.54 |
| Price/Book(x) | 1.93 | 1.79 | 4.41 | 4.13 | 1.17 |
| Yield(%) | - | 1.29 | 0.57 | 0.80 | 3.96 |
| EV/Net Sales(x) | 1.92 | 1.49 | 2.57 | 1.99 | 0.48 |
| EV/Core EBITDA(x) | 18.26 | 10.37 | 10.78 | 8.84 | 2.81 |
| EV/EBIT(x) | 24.38 | 12.57 | 11.93 | 9.42 | 3.73 |
| EV/CE(x) | 1.83 | 1.67 | 3.44 | 2.56 | 0.66 |
| M Cap / Sales | 1.88 | 1.52 | 2.69 | 2.06 | 0.52 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -5.97 | -22.36 | 7.78 | 25.21 | 39.43 |
| Core EBITDA Growth(%) | -31.13 | -53.40 | 14.26 | 64.07 | 55.28 |
| EBIT Growth(%) | -37.46 | -57.46 | 10.10 | 104.19 | 37.42 |
| PAT Growth(%) | -40.65 | -59.54 | 17.44 | 91.08 | 71.86 |
| EPS Growth(%) | -40.65 | -59.54 | 17.44 | 91.08 | 71.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.08 | 0.04 | - | 0.03 | 0.02 |
| Current Ratio(x) | 4.32 | 6.70 | 12.52 | 3.12 | 2.78 |
| Quick Ratio(x) | 2.33 | 3.23 | 9.02 | 1.75 | 1.21 |
| Interest Cover(x) | 11.21 | 65.09 | 238.42 | 51.15 | 20.53 |
| Total Debt/Mcap(x) | 0.04 | 0.02 | - | 0.01 | 0.02 |
Compare Financial Ratios of peers of RESONANCE SPECIALTIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| RESONANCE SPECIALTIES | ₹107.3 Cr | -7.4% | -7.8% | -15.9% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹142,253.0 Cr | -4.3% | -12.3% | 6.5% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹80,715.8 Cr | -7.9% | -16.4% | 39.7% | Stock Analytics | |
| SRF | ₹74,607.2 Cr | 9.1% | 9.5% | 12.6% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹40,936.7 Cr | -5.1% | -14.8% | 10.8% | Stock Analytics | |
| DEEPAK NITRITE | ₹31,744.8 Cr | -5.4% | -13.1% | -0.6% | Stock Analytics | |
RESONANCE SPECIALTIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RESONANCE SPECIALTIES | -7.4% |
-7.8% |
-15.9% |
| SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses
